Delivery Order SPE2DR25D3504-SPE2DR26F7CJ2
- Not listed
- The Defense Logistics Agency awarded a $1,155.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablets (21-count packages) on December 30, 2025, with completion targeted for December 31, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $12,155.23 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under full and open competition. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14,...
- The Defense Logistics Agency awarded a delivery order valued at $3,500.57 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance taking place at its corporate office...
- The Defense Logistics Agency has awarded a delivery order valued at $1,155.38 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 31, 2025. The award date of December 30, 2025 indicates this is a final delivery order placed under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency has awarded a delivery order valued at $63,466.34 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages). This firm fixed-price, competitively awarded contract (with no set-aside designation) is effective through November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-count packages) valued at $8,991.35 under a firm fixed-price contract type. The award, announced on June 9, 2025, with an ultimate completion date of June 10, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, supplying this...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Loestrin 21 1-20 Tablet in quantities of 21 tablets, with a contract ceiling value of $2,983.50 and a firm fixed price structure. The contract is non-set-aside and represents a competitive award for pharmaceutical supply. This delivery order is completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,770.40 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's broader...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7CJ2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,733.36 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was issued without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is structured as a child contract under AmerisourceBergen's parent company, Cencora, Inc., which operates the pharmaceutical distribution and healthcare solutions business under the AmerisourceBergen brand name. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, designated as SPE2DX. This comprehensive pharmaceutical supply vehicle enables the company to deliver a broad range of prescription medications, generic drugs, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems. The award reflects the contractor's established capability to supply critical pharmaceutical commodities through open competition and demonstrates the efficiency of leveraging existing IDC vehicles for routine medical product procurement by federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/12/26 |